Metraipolis › archive › dc_a03ef5908714
Serum Uric Acid Trajectories in Multiple Sclerosis: A 5-Year Longitudinal Comparison of High- and Moderate-Efficacy Therapies — Europe PMC PMID:42201048
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42201048
- DOI
- 10.3390/medsci14020256
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T07:26:51.426Z
- SHA-256 of the archived text
67e4ad860308d9d223e49227f7454566d19207a16b76eaf92366141d348ed3a4- Stable URL of this page
https://metraipolis.com/documento/dc_a03ef5908714
How to cite
Serum Uric Acid Trajectories in Multiple Sclerosis: A 5-Year Longitudinal Comparison of High- and Moderate-Efficacy Therapies — Europe PMC PMID:42201048 — Europe PMC (en), https://europepmc.org/article/MED/42201048 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a03ef5908714 (Metraipolis archive dc_a03ef5908714, sha256 67e4ad860308d9d223e49227f7454566d19207a16b76eaf92366141d348ed3a4)
BibTeX
@misc{dca03ef5908714,
title = {Serum Uric Acid Trajectories in Multiple Sclerosis: A 5-Year Longitudinal Comparison of High- and Moderate-Efficacy Therapies — Europe PMC PMID:42201048},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42201048},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a03ef5908714; sha256 67e4ad860308d9d223e49227f7454566d19207a16b76eaf92366141d348ed3a4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42201048. Agents can read the archived copy with the MCP tool read_document.